BioLife Solutions (BLFS)
(Delayed Data from NSDQ)
$21.52 USD
+1.22 (6.01%)
Updated Jun 10, 2024 04:00 PM ET
After-Market: $21.49 -0.03 (-0.14%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth A Momentum D VGM
Brokerage Reports
BioLife Solutions, Inc. [BLFS]
Reports for Purchase
Showing records 61 - 80 ( 91 total )
Company: BioLife Solutions, Inc.
Industry: Medical - Products
2019 Financials Reported; Rocky Terrain Ahead; Lowering PT to $17
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: BioLife Solutions, Inc.
Industry: Medical - Products
Multiple Recent Acquisitions Bolster Trajectory; Reiterate Buy and Raising Target to $26
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: BioLife Solutions, Inc.
Industry: Medical - Products
Co-Investment Accelerator Program Established; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: BioLife Solutions, Inc.
Industry: Medical - Products
2Q19 Financial Results Reported; Top- and Bottom- Line In-Line; Guidance Modestly Improved; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: BioLife Solutions, Inc.
Industry: Medical - Products
SAVSU Partnership With United Cargo; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: BioLife Solutions, Inc.
Industry: Medical - Products
Powered by Cell and Gene Therapy Manufacturing Industry Growth; Initiating at Buy and $23 Price Target
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R